Works matching IS 0167594X AND DT 2017 AND VI 131 AND IP 3


Results: 21
    1

    Reverse phase protein arrays enable glioblastoma molecular subtyping.

    Published in:
    Journal of Neuro-Oncology, 2017, v. 131, n. 3, p. 437, doi. 10.1007/s11060-016-2316-5
    By:
    • Hutter, Gregor;
    • Sailer, Martin;
    • Azad, Tej;
    • Bueren, André;
    • Nollau, Peter;
    • Frank, Stephan;
    • Tostado, Cristobal;
    • Sarvepalli, Durga;
    • Ghosh, Arkasubhra;
    • Ritz, Marie-Françoise;
    • Boulay, Jean-Louis;
    • Mariani, Luigi
    Publication type:
    Article
    2
    3

    Epidemiology for primary brain tumors: a nationwide population-based study.

    Published in:
    Journal of Neuro-Oncology, 2017, v. 131, n. 3, p. 525, doi. 10.1007/s11060-016-2318-3
    By:
    • Darlix, Amélie;
    • Zouaoui, Sonia;
    • Rigau, Valérie;
    • Bessaoud, Faiza;
    • Figarella-Branger, Dominique;
    • Mathieu-Daudé, Hélène;
    • Trétarre, Brigitte;
    • Bauchet, Fabienne;
    • Duffau, Hugues;
    • Taillandier, Luc;
    • Bauchet, Luc
    Publication type:
    Article
    4

    Correlation of higher levels of soluble TNF-R1 with a shorter survival, independent of age, in recurrent glioblastoma.

    Published in:
    Journal of Neuro-Oncology, 2017, v. 131, n. 3, p. 449, doi. 10.1007/s11060-016-2319-2
    By:
    • Ahluwalia, Manmeet;
    • Bou-Anak, Stephanie;
    • Burgett, Monica;
    • Sarmey, Nehaw;
    • Khosla, Divya;
    • Dahiya, Saurabh;
    • Weil, Robert;
    • Bae, Eunnyung;
    • Huang, Ping;
    • McGraw, Mary;
    • Grove, Lisa;
    • Olman, Mitchell;
    • Prayson, Richard;
    • Suh, John;
    • Gillespie, G.;
    • Barnholtz-Sloan, Jill;
    • Nowacki, Amy;
    • Barnett, Gene;
    • Gladson, Candece
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma.

    Published in:
    Journal of Neuro-Oncology, 2017, v. 131, n. 3, p. 603, doi. 10.1007/s11060-016-2332-5
    By:
    • Kalpathy-Cramer, Jayashree;
    • Chandra, Vyshak;
    • Da, Xiao;
    • Ou, Yangming;
    • Emblem, Kyrre;
    • Muzikansky, Alona;
    • Cai, Xuezhu;
    • Douw, Linda;
    • Evans, John;
    • Dietrich, Jorg;
    • Chi, Andrew;
    • Wen, Patrick;
    • Stufflebeam, Stephen;
    • Rosen, Bruce;
    • Duda, Dan;
    • Jain, Rakesh;
    • Batchelor, Tracy;
    • Gerstner, Elizabeth
    Publication type:
    Article
    17

    Combined BRAF and MEK blockade for BRAF-mutant gliomas.

    Published in:
    Journal of Neuro-Oncology, 2017, v. 131, n. 3, p. 495, doi. 10.1007/s11060-016-2333-4
    By:
    • Zhang, Jie;
    • Yao, Tsun-Wen;
    • Hashizume, Rintaro;
    • Hariono, Sujatmi;
    • Barkovich, Krister;
    • Fan, Qi-Wen;
    • Prados, Michael;
    • James, C.;
    • Weiss, William;
    • Nicolaides, Theodore
    Publication type:
    Article
    18

    Comparing pre-operative stereotactic radiosurgery (SRS) to post-operative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysis.

    Published in:
    Journal of Neuro-Oncology, 2017, v. 131, n. 3, p. 611, doi. 10.1007/s11060-016-2334-3
    By:
    • Patel, Kirtesh;
    • Burri, Stuart;
    • Boselli, Danielle;
    • Symanowski, James;
    • Asher, Anthony;
    • Sumrall, Ashley;
    • Fraser, Robert;
    • Press, Robert;
    • Zhong, Jim;
    • Cassidy, Richard;
    • Olson, Jeffrey;
    • Curran, Walter;
    • Shu, Hui-Kuo;
    • Crocker, Ian;
    • Prabhu, Roshan
    Publication type:
    Article
    19
    20
    21